The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis
Details
Publication Year 2023-02-08,Volume 24,Issue #4,Page 3356
Journal Title
International Journal of Molecular Sciences
Abstract
Glioblastoma cells adapt to changes in glucose availability through metabolic plasticity allowing for cell survival and continued progression in low-glucose concentrations. However, the regulatory cytokine networks that govern the ability to survive in glucose-starved conditions are not fully defined. In the present study, we define a critical role for the IL-11/IL-11Rα signalling axis in glioblastoma survival, proliferation and invasion when cells are starved of glucose. We identified enhanced IL-11/IL-11Rα expression correlated with reduced overall survival in glioblastoma patients. Glioblastoma cell lines over-expressing IL-11Rα displayed greater survival, proliferation, migration and invasion in glucose-free conditions compared to their low-IL-11Rα-expressing counterparts, while knockdown of IL-11Rα reversed these pro-tumorigenic characteristics. In addition, these IL-11Rα-over-expressing cells displayed enhanced glutamine oxidation and glutamate production compared to their low-IL-11Rα-expressing counterparts, while knockdown of IL-11Rα or the pharmacological inhibition of several members of the glutaminolysis pathway resulted in reduced survival (enhanced apoptosis) and reduced migration and invasion. Furthermore, IL-11Rα expression in glioblastoma patient samples correlated with enhanced gene expression of the glutaminolysis pathway genes GLUD1, GSS and c-Myc. Overall, our study identified that the IL-11/IL-11Rα pathway promotes glioblastoma cell survival and enhances cell migration and invasion in environments of glucose starvation via glutaminolysis.
Publisher
MDPI
Keywords
Humans; Cell Line; Cell Line, Tumor; *Glioblastoma/metabolism; Glucose/metabolism; Interleukin-11/metabolism; Receptors, Interleukin-11; Il-11; glioblastoma; glutaminolysis; invasion; survival
Research Division(s)
Personalised Oncology
PubMed ID
36834778
Open Access at Publisher's Site
https://doi.org/10.3390/ijms24043356
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-03-08 03:16:07
Last Modified: 2023-03-08 04:07:15
An error has occurred. This application may no longer respond until reloaded. Reload 🗙